search
European Commission
Trends
- 1Irish regulator fines Google €403 million over location data●Data Protection Commission fines Google €403M over processing of location data
Ireland's Data Protection Commission has fined Google €403 million following an inquiry into how the company processes users' location data. The decision, announced by the watchdog, adds to a series of major European privacy enforcement actions against large technology firms over how they collect and handle personal information without sufficient legal basis or user clarity.
- 2EU commits 710 million euros in global crisis aid●EU stellt 710 Millionen Euro für weltweite Krisenhilfe bereit Weltweit leiden Menschen unter den Folgen von Naturkatastr
The European Union has announced 710 million euros in new humanitarian aid for people affected by natural disasters and conflicts worldwide. Commission President Ursula von der Leyen said a large share of the funding is earmarked for Africa. The package responds to growing humanitarian needs driven by climate-related catastrophes and ongoing wars.
- 3US reportedly intervenes in Musk's €120M dispute with Brussels●Uncle Sam wants in on Musk's €120M fight with Brussels
Elon Musk is locked in a €120 million legal fight with the European Commission, and the US government has reportedly asked to join the case on his side. The dispute concerns EU regulation of Musk's businesses, and Washington's decision to weigh in raises the stakes, turning a corporate complaint into a transatlantic clash over tech regulation and jurisdiction.
- 4Europe short a million health workers, Parliament seeks EU funding▼Europe is short of a million health workers. Parliament asks Brussels for money
The European Parliament is calling on the European Commission to provide funding to address a shortage of around one million health workers across the EU. Staff shortages in hospitals, care homes and primary care have been flagged as a growing risk to health systems, particularly as populations age and workforce attrition accelerates. MEPs want Brussels to treat health workforce shortages as a European-level problem requiring dedicated financial support.
- 5Greek MEP calls von der Leyen 'racist' in EU Parliament outburst●Pöbel-Attacke im EU-Parlament: Griechin beschimpft von der Leyen als „Rassistin“
A Greek member of the European Parliament publicly insulted European Commission President Ursula von der Leyen, calling her a 'racist' during a session at the EU Parliament in Strasbourg or Brussels. The incident, described in German media as a 'mob attack', is drawing wide attention and sparking debate about conduct and political tensions inside the assembly.
- 6Von der Leyen announces €710 million for displaced people in Africa▼President von der Leyen announces €710 million to support displaced people in Africa and global crisis relief
European Commission President Ursula von der Leyen has announced €710 million in funding to support displaced people in Africa and broader global crisis relief efforts. The package falls under the EU's humanitarian aid operations and is aimed at addressing rising needs among refugee and displaced populations across the continent.
- 7Von der Leyen floats Canada associate EU membership▼Von der Leyen raises Canada’s possible associate EU membership
European Commission President Ursula von der Leyen has raised the idea of Canada obtaining associate membership of the European Union, opening a debate about a closer EU-Canada relationship outside full accession. The suggestion has drawn attention among EU and Canadian observers, as associate membership is a novel status with unclear legal contours, and it fits into broader discussions on deepening ties with close allies.
- 8EU approves first drug for cerebral adrenoleukodystrophy▼European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease
The European Commission has granted marketing authorization for NEZGLYAL (leriglitazone), making it the first pharmacological treatment approved for cerebral adrenoleukodystrophy, a rare and rapidly progressive neurodegenerative disease that primarily affects young boys. Until now, care options for cALD were limited mainly to stem cell transplantation in eligible patients. The approval is being highlighted as a significant milestone for families affected by the rare disease and for rare-disease drug development in Europe.